SMAIO (Software, Machines and Adaptative Implants in Orthopaedics – Euronext Growth Paris, ISIN: FR0014005I80 / Ticker: ALSMA ...

DALLAS & LYON, France, January 27, 2025--(BUSINESS WIRE)--Regulatory News: SMAIO (Software, Machines and Adaptative Implants in Orthopaedics – Euronext Growth Paris, ISIN: FR0014005I80 / Ticker ...

NuVasive and orthopedic devicemaker SMAIO mutually decided to end their software co-development efforts, according to a Jan. 27 news release.

In the first quarter of 2022, SMAIO and NuVasive, a global leader in spine technology innovation, entered into a development and license agreement to further advance SMAIO’s surgical planning ...

From acquisitions to quarterly updates, here are seven key developments from spine and orthopedic devicemakers since Jan. 22.

GMED's strong synergies from the NuVasive merger and robust performance in the musculoskeletal solutions space bode well for investors.

Ventris Medical received 510(k) clearance for its bone graft containment technology for use in spinal fusion procedures.The ...

Globus Medical Inc. (NYSE:GMED) shares have reached an unprecedented peak, touching an all-time high of $93.68. With a market capitalization of $12.7 billion and an impressive revenue growth of 102.1% ...

The Global MedTech Industry Outlook for 2025 aims to provide insights into the anticipated performance of the MedTech sectors ...

In the third quarter, Globus' proforma musculoskeletal revenues (assuming NuVasive revenue in the year-ago period) improved 5.4%, marking it the fourth consecutive quarter of pro forma ...

With the proliferation of remote proceedings that was borne out of the recent global pandemic, the advent of trials playing ...